1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Neutropenia in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (45.45) | 18.7374 |
1990's | 14 (42.42) | 18.2507 |
2000's | 3 (9.09) | 29.6817 |
2010's | 1 (3.03) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blair, IA; Hergott, CB; Mesaros, C; Naidu, NA; Roche, AM; Weiser, JN | 1 |
Barberà, JA; Casas, A; Chung, KF; Gabrijelcic, J; Rabinovich, RA; Roca, J; Rodríguez-Roisin, R | 1 |
Asano, K; Fukunaga, K; Ishizaka, A; Nakajima, T; Naoki, K; Niimi, K; Oguma, T; Satoh, N; Shiomi, T; Shiraishi, Y; Suzuki, Y; Yamaguchi, K | 1 |
Alberton, M; Bussolino, F; Caligaris Cappio, F; Camussi, G; Coda, R; Macchiorlatti, E; Roffinello, C; Segoloni, G; Tetta, C | 1 |
Bussolino, F; Camussi, G; Tetta, C | 1 |
Björk, J; Smedegård, G | 1 |
Bussolino, F; Camussi, G; Chiara Deregibus, M; Segoloni, G; Tetta, C | 1 |
Bass, DA; DeChatelet, LR; Lewis, JC; McCall, CE; Miller, CH; O'Flaherty, JT; Waite, M; Wykle, RL | 1 |
Crawford, MH; Fitzpatrick, FA; Hanahan, DJ; McManus, LM; O'Rourke, RA; Pinckard, RN | 1 |
Demopoulos, CA; Hanahan, DJ; McManus, LM; Pinckard, RN | 1 |
Berndt, MC; Coughlan, AF; Dunlop, LC; Hancock, WW; Hau, H | 1 |
Filep, JG; Földes-Filep, E; Fournier, A | 1 |
Chang, SW | 1 |
Barnes, PJ; Carty, TJ; Chung, KF; Eskra, JD; O'Connor, BJ; Uden, S | 1 |
Eling, WM; Hermsen, CC; Huys, HL; van der Meer, JW; Vogels, MT | 1 |
Barberà, JA; Chung, KF; Lomeña, F; MacNee, W; Masclans, JR; Pavia, J; Piera, C; Roca, J; Rodriguez-Roisin, R | 1 |
Battistini, B; Farmer, P; Johnson, RJ; O'Brien, JG; Sirois, P; Zaharia, F | 1 |
Barberà, JA; Chung, KF; Gómez, FP; Iglesia, R; Roca, J; Rodriguez-Roisin, R | 1 |
Ashida, Y; Kitao, S; Kobayashi, K; Kyotani, K; Mochizuki, T; Nishizono, K; Scott, MA; Tsuchiya, R; Yamada, T | 1 |
Kistler, EB; Mitsuoka, H; Schmid-Schönbein, GW | 1 |
Goto, F; Yoshikawa, D | 1 |
Chen, YH; Morimoto, S; Nakamoto, Y; Ogihara, T; Sakaguchi, K | 1 |
Candler, RV; Carroll, RC; Jones, JB; Lothrop, CD; Pratt, HL; Urso, IM | 1 |
Barnes, PJ; Chung, KF; Kioumis, I; Lammers, JW; McCusker, M; Nichol, GM | 1 |
Keenan, CM; Wallace, JL | 1 |
McDonald, JW; Smallbone, BW; Taylor, NE | 1 |
Biftu, T; Doebber, TW; Wu, MS | 2 |
Mata, R; Muniain, MA; Pérez, JJ; Pozuelo, F; Rodríguez, MC; Rodríguez, MD; Romero, A | 1 |
Braquet, P; Cano, E; Fernandez-Gallardo, S; Sanchez Crespo, M | 1 |
Barnes, PJ; Chung, KF; McCusker, M; Roberts, NM | 1 |
Chang, SW; Feddersen, CO; Henson, PM; Voelkel, NF | 1 |
Issekutz, AC; Szpejda, M | 1 |
6 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Neutropenia
Article | Year |
---|---|
Formoterol protects against platelet-activating factor-induced effects in asthma.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Airway Resistance; Asthma; Cough; Cross-Over Studies; Double-Blind Method; Dyspnea; Ethanolamines; Female; Flushing; Formoterol Fumarate; Humans; Male; Neutropenia; Platelet Activating Factor; Pulmonary Circulation; Pulmonary Gas Exchange; Ventilation-Perfusion Ratio | 2004 |
Inhibitory effect of UK,74505, a potent and specific oral platelet activating factor (PAF) receptor antagonist, on airway and systemic responses to inhaled PAF in humans.
Topics: Administration, Inhalation; Administration, Oral; Airway Resistance; Bronchoconstriction; Dihydropyridines; Dose-Response Relationship, Drug; Double-Blind Method; Eicosanoids; Humans; Imidazoles; Leukocyte Count; Leukotriene E4; Male; Neutropenia; Neutrophils; Platelet Activating Factor; Thromboxane B2 | 1994 |
Salbutamol reduces pulmonary neutrophil sequestration of platelet-activating factor in humans.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Cross-Over Studies; Double-Blind Method; Erythrocytes; Female; Humans; Indium Radioisotopes; Lung; Male; Neutropenia; Neutrophils; Platelet Activating Factor; Radionuclide Imaging; Sodium Pertechnetate Tc 99m | 1996 |
The effects of 5-lipoxygenase inhibition by zileuton on platelet-activating-factor-induced pulmonary abnormalities in mild asthma.
Topics: Adult; Airway Resistance; Asthma; Cross-Over Studies; Double-Blind Method; Female; Humans; Hydroxyurea; Leukotrienes; Lipoxygenase Inhibitors; Male; Neutropenia; Oxygen; Platelet Activating Factor; Pulmonary Gas Exchange; Respiratory Mechanics; Ventilation-Perfusion Ratio | 1998 |
Effects of prostacyclin on bronchoconstriction and neutropenia induced by inhaled platelet-activating factor in man.
Topics: Administration, Inhalation; Adult; Agranulocytosis; Blood Pressure; Bronchial Spasm; Epoprostenol; Forced Expiratory Flow Rates; Heart Rate; Humans; Infusions, Intravenous; Male; Neutropenia; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Random Allocation | 1990 |
Effect of a PAF antagonist, BN52063, on PAF-induced bronchoconstriction in normal subjects.
Topics: Adult; Bronchi; Female; Humans; Lactones; Methacholine Compounds; Neutropenia; Plant Extracts; Platelet Activating Factor; Respiratory Function Tests; Skin Tests | 1988 |
27 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Neutropenia
Article | Year |
---|---|
Bacterial exploitation of phosphorylcholine mimicry suppresses inflammation to promote airway infection.
Topics: Animals; Bacterial Proteins; Carrier Proteins; Carrier State; Cell Wall; Haemophilus Infections; Haemophilus influenzae; Humans; Immune Evasion; Immunity, Innate; Immunoglobulin D; Lipoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Mimicry; N-Formylmethionine Leucyl-Phenylalanine; Nasal Cavity; Neutropenia; Neutrophil Activation; Neutrophils; Phagocytosis; Phosphorylcholine; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pneumococcal Infections; Proteolysis; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Species Specificity; Streptococcus pneumoniae | 2015 |
PAF responsiveness in Japanese subjects with plasma PAF acetylhydrolase deficiency.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Administration, Inhalation; Adult; Alleles; Asthma; Bronchoconstriction; Female; Heterozygote; Homozygote; Humans; Japan; Kinetics; Lymphocytes; Male; Neutropenia; Platelet Activating Factor; Respiratory Function Tests | 2004 |
Effect of prostacyclin (PGI2) on immune-complex-induced neutropenia.
Topics: Agranulocytosis; Animals; Antigen-Antibody Complex; Cell Aggregation; Epoprostenol; Neutropenia; Neutrophils; Platelet Activating Factor; Prostaglandins; Rabbits; Thrombocytopenia | 1983 |
Inhibitory effect of prostacyclin (PGI2) on neutropenia induced by intravenous injection of platelet-activating-factor (PAF) in the rabbit.
Topics: Agranulocytosis; Animals; Epoprostenol; Female; Kinetics; Male; Neutropenia; Platelet Activating Factor; Prostaglandins; Rabbits | 1983 |
Acute microvascular effects of PAF-acether, as studied by intravital microscopy.
Topics: Animals; Cheek; Cricetinae; Extravasation of Diagnostic and Therapeutic Materials; Indomethacin; Injections, Intravenous; Male; Mesocricetus; Microcirculation; Neutropenia; Platelet Activating Factor; Vasoconstriction | 1983 |
Neutropenia induced by platelet-activating factor (PAF-acether) released from neutrophils: the inhibitory effect of prostacyclin (PGI2).
Topics: Agranulocytosis; Animals; Cell Aggregation; Epoprostenol; Humans; In Vitro Techniques; Lysophosphatidylcholines; Neutropenia; Neutrophils; Platelet Activating Factor; Prostaglandins; Rabbits | 1981 |
Neutrophil responses to platelet-activating factor.
Topics: Animals; Glucuronidase; Humans; In Vitro Techniques; Lysophosphatidylcholines; Muramidase; Neutropenia; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Rabbits | 1981 |
Acetyl glyceryl ether phosphorylcholine. Intravascular alterations following intravenous infusion into the baboon.
Topics: Animals; Blood Cell Count; Blood Coagulation Factors; Blood Proteins; Hematocrit; Infusions, Parenteral; Lysophosphatidylcholines; Neutropenia; Papio; Platelet Activating Factor; Platelet Factor 4; Species Specificity; Thrombocytopenia; Thromboxane B2; Thromboxanes | 1981 |
Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.
Topics: Animals; Basophils; Blood Platelets; Dose-Response Relationship, Drug; Female; Infusions, Parenteral; Leukocyte Count; Lysophosphatidylcholines; Male; Neutropenia; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Platelet Factor 4; Rabbits; Thrombocytopenia | 1980 |
P-selectin and platelet-activating factor mediate initial endotoxin-induced neutropenia.
Topics: Animals; Antibodies; Cells, Cultured; Endotoxins; Humans; Male; Neutropenia; Neutrophils; P-Selectin; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats | 1994 |
Acute pro-inflammatory actions of endothelin-1 in the guinea-pig lung: involvement of ETA and ETB receptors.
Topics: Animals; Azepines; Blood Pressure; Bosentan; Bronchopulmonary Sequestration; Capillary Permeability; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelins; Guinea Pigs; In Vitro Techniques; Indoles; Injections, Intravenous; Lung; Macrophages, Alveolar; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutropenia; Neutrophils; Peptide Fragments; Plasma Volume; Platelet Activating Factor; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Sulfonamides; Superoxides; Tetradecanoylphorbol Acetate | 1995 |
TNF potentiates PAF-induced pulmonary vasoconstriction in the rat: role of neutrophils and thromboxane A2.
Topics: Animals; Blood Pressure; Drug Synergism; Imidazoles; In Vitro Techniques; Lipopolysaccharides; Male; Neutropenia; Neutrophils; Platelet Activating Factor; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Thromboxane A2; Thromboxane-A Synthase; Tumor Necrosis Factor-alpha; Vasoconstriction | 1994 |
Roles of tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, platelet-activating factor, and arachidonic acid metabolites in interleukin-1-induced resistance to infection in neutropenic mice.
Topics: Animals; Arachidonic Acid; Female; Gram-Negative Bacterial Infections; Granulocyte-Macrophage Colony-Stimulating Factor; Immunoglobulin G; Interleukin-1; Mice; Neutropenia; Platelet Activating Factor; Tumor Necrosis Factor-alpha | 1994 |
Effects of tranexamic acid and aprotinin on PAF-induced vascular permeability in normal, thrombocytopenic or neutropenic rats.
Topics: Animals; Antifibrinolytic Agents; Aprotinin; Bronchi; Capillary Permeability; Male; Neutropenia; Platelet Activating Factor; Rats; Rats, Wistar; Serine Proteinase Inhibitors; Thrombocytopenia; Trachea; Tranexamic Acid; Trypsin Inhibitors | 1997 |
Role of platelet activating factor in development of thrombocytopenia and neutropenia in dogs with endotoxemia.
Topics: Animals; Blood Coagulation Tests; Dog Diseases; Dogs; Endotoxemia; Female; Isoquinolines; Leukocyte Count; Lipopolysaccharides; Male; Neutropenia; Pilot Projects; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Count; Pyridinium Compounds; Radioimmunoassay; Tetrahydroisoquinolines; Thrombocytopenia | 1999 |
Protease inhibition in the intestinal lumen: attenuation of systemic inflammation and early indicators of multiple organ failure in shock.
Topics: Animals; Blood Pressure; Endopeptidases; Esters; Gabexate; Guanidines; Humans; In Vitro Techniques; Inflammation; Intestinal Mucosa; Intestines; Leukocytes; Male; Multiple Organ Failure; N-Formylmethionine Leucyl-Phenylalanine; Neutropenia; Phospholipases A; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reperfusion; Serine Endopeptidases; Serine Proteinase Inhibitors; Shock; Splanchnic Circulation; Survival Rate | 2002 |
Effect of platelet-activating factor antagonist and leukotriene antagonist on endotoxin shock in the rat: role of the leukocyte.
Topics: Animals; Chromones; Leukocyte Count; Leukocytes; Leukotriene Antagonists; Male; Neutropenia; Phospholipid Ethers; Platelet Activating Factor; Rats; Rats, Wistar; Shock, Septic; Vinblastine | 1992 |
Increases in circulating level of platelet-activating factor lag behind transient neutropenia during hemodialysis with cuprophane membranes.
Topics: Adult; Aged; Cellulose; Complement System Proteins; Humans; Kidney Failure, Chronic; Kidneys, Artificial; Male; Middle Aged; Neutropenia; Platelet Activating Factor; Platelet Count; Renal Dialysis | 1991 |
Characterization of platelet function in cyclic hematopoietic dogs.
Topics: Animals; Blood Proteins; Dog Diseases; Dogs; Female; Hematopoiesis; Heterozygote; Male; Neutropenia; Periodicity; Phosphorylation; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Storage Pool Deficiency; Thrombin; Type C Phospholipases | 1991 |
Leukotriene B4 potentiates colonic ulceration in the rat.
Topics: Administration, Rectal; Animals; Colitis; Drug Synergism; Ethanol; Leukotriene B4; Leukotrienes; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutropenia; Platelet Activating Factor; Rats; Rats, Inbred Strains; Ulcer | 1990 |
Effects of L-652,731, a platelet-activating factor (PAF) receptor antagonist, on PAF- and complement-induced pulmonary hypertension in sheep.
Topics: Animals; Aspirin; Complement Activation; Complement System Proteins; Dose-Response Relationship, Drug; Endotoxins; Female; Furans; Hypertension, Pulmonary; Hypoxia; Neutropenia; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sheep; Thromboxanes; Zymosan | 1987 |
Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731.
Topics: Anaphylaxis; Animals; Antigen-Antibody Complex; Capillary Permeability; Female; Furans; Hydrolases; Hypotension; Kinetics; Liver; Lysosomes; Neutropenia; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1986 |
[Effect of corticosteroids, quinacrine and L-652, 731 on experimental aggregation of polymorphonuclear leukocytes induced by complement and platelet activating factor (PAF)].
Topics: Agranulocytosis; Animals; Cell Aggregation; Complement System Proteins; Furans; Methylprednisolone; Methylprednisolone Hemisuccinate; Neutropenia; Platelet Activating Factor; Quinacrine; Rabbits; Zymosan | 1988 |
Role of paf-acether in the mediation of pathophysiological responses to aggregated immunoglobulins. Studies with the platelet-activating factor receptor antagonist BN 52021.
Topics: Acetylglucosaminidase; Animals; Diterpenes; Ginkgolides; Humans; Immunoglobulin G; Lactones; Metabolic Clearance Rate; Neutropenia; Platelet Activating Factor; Rats; Rats, Inbred Strains; Tissue Plasminogen Activator | 1988 |
Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.
Topics: Animals; Blood Pressure; Endotoxins; Hemodynamics; Lung; Male; Neutropenia; Phospholipid Ethers; Platelet Activating Factor; Pulmonary Circulation; Quinolinium Compounds; Rats; Rats, Inbred Strains; Salmonella enteritidis; Thiazoles; Time Factors; Vasoconstriction; Vinblastine | 1987 |
Inhibition of the platelet activating factor (PAF)-induced in vivo responses in rats by trans-2,5-(3,4,5-trimethoxyphenyl) tetrahydrofuran (L-652,731), a PAF receptor antagonist.
Topics: Acetylglucosaminidase; Animals; Blood Pressure; Endotoxins; Female; Furans; Hydrolases; Leukopenia; Lysosomes; Neutropenia; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1986 |
Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988.
Topics: Acute Disease; Animals; Blood Platelets; Capillary Permeability; Cell Movement; Inflammation; Leukocytes; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutropenia; Phospholipid Ethers; Platelet Activating Factor; Rabbits; Regional Blood Flow; Serum Albumin; Skin; Thiazoles; Thrombocytopenia | 1986 |